Kyoko Otsuka

1.0k citations

27 papers · 749 indexed · h-index 15

Pulmonary and Respiratory Medicine top 5%
Oncology top 10%
Molecular Biology
Cancer Research
Epidemiology

Co-authors: Keisuke Tomii Kazuma Nagata Nobuyuki Katakami Ryo Tachikawa Akito Hata Shiro Fujita Reiko Kaji Kojiro Otsuka
Topics: Lung Cancer Treatments and Mutations (16 papers)Lung Cancer Research Studies (7 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers)
Cited by: Pulmonary and Respiratory Medicine Oncology Cancer Research
Journals: Journal of Clinical Oncology PLoS ONE Cancer
Partner nations: Japan Australia United States

In The Last Decade

Kyoko Otsuka

27 papers receiving 740 citations

Peers

Countries citing papers authored by Kyoko Otsuka

Since Specialization

Citations

This map shows the geographic impact of Kyoko Otsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Otsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Otsuka more than expected).

Fields of papers citing papers by Kyoko Otsuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoko Otsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Otsuka. The network helps show where Kyoko Otsuka may publish in the future.

Co-authorship network of co-authors of Kyoko Otsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoko Otsuka. A scholar is included among the top collaborators of Kyoko Otsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoko Otsuka. Kyoko Otsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital 2015 ·BMC Pulmonary Medicine ·Takeshi Matsumoto,Keisuke Tomii,Ryo Tachikawa,Kojiro Otsuka,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Michiaki Mishima,Kazuo Chin	17
2	Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer 2015 ·PLoS ONE ·Shiro Fujita,Katsuhiro Masago,Jumpei Takeshita,Chiyuki Okuda,Kyoko Otsuka,Akito Hata,Reiko Kaji,Nobuyuki Katakami,Yukio Hirata	6
3	Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations 2015 ·BMC Cancer ·Katsuhiro Masago,Shiro Fujita,Miho Muraki,Akito Hata,Chiyuki Okuda,Kyoko Otsuka,Reiko Kaji,Jumpei Takeshita,Ryoji Kato,Nobuyuki Katakami,Yukio Hirata	27
4	EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer 2015 ·Cancer Chemotherapy and Pharmacology ·Kyoko Otsuka,Akito Hata,Jumpei Takeshita,Chiyuki Okuda,Reiko Kaji,Katsuhiro Masago,Shiro Fujita,Nobuyuki Katakami	39
5	A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapy. 2015 ·PubMed ·Jumpei Takeshita,Katsuhiro Masago,Ryoji Kato,Kyoko Otsuka,Chiyuki Okuda,Akito Hata,Reiko Kaji,Shiro Fujita,Kenji Takayama,Masaki Kokubo,Nobuyuki Katakami	5
6	Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolam 2015 ·Experimental and Therapeutic Medicine ·Takeshi Matsumoto,Kojiro Otsuka,Ryoji Kato,(unknown),Takehiro Otoshi,Daichi Fujimoto,Takahisa Kawamura,(unknown),Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Keisuke Tomii	9
7	Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients 2014 ·Molecular and Clinical Oncology ·Jumpei Takeshita,Katsuhiro Masago,Shiro Fujita,Akito Hata,Reiko Kaji,Takahisa Kawamura,(unknown),Takeshi Matsumoto,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Kojiro Otsuka,Keisuke Tomii,Takashi Shintani,Kenji Takayama,Masaki Kokubo,Nobuyuki Katakami	1
8	Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis 2014 ·Clinical & Experimental Metastasis ·Daichi Fujimoto,Hiroyuki Ueda,(unknown),Ryoji Kato,Takehiro Otoshi,Takahisa Kawamura,(unknown),(unknown),Takeshi Matsumoto,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Kojiro Otsuka,Nobuyuki Katakami,Keisuke Tomii	47
9	The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease 2014 ·Cancer Chemotherapy and Pharmacology ·(unknown),Daichi Fujimoto,Ryoji Kato,Takehiro Otoshi,Takahisa Kawamura,(unknown),Takeshi Matsumoto,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Kojiro Otsuka,Nobuyuki Katakami,Keisuke Tomii	39
10	Prognostic Value of Bronchoalveolar Lavage in Patients with Non-HIV Pneumocystis Pneumonia 2014 ·Internal Medicine ·(unknown),Ryo Tachikawa,Keisuke Tomii,Kazuma Nagata,Kojiro Otsuka,Atsushi Nakagawa,Kyoko Otsuka,Takeshi Matsumoto,Kazuya Monden,Jumpei Takeshita,Kosuke Tanaka,Takahisa Kawamura,Takehiro Otoshi,Daichi Fujimoto	14
11	Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation 2013 ·Journal of Thoracic Oncology ·Kosuke Tanaka,Akito Hata,Reiko Kaji,Shiro Fujita,Takehiro Otoshi,Daichi Fujimoto,Takahisa Kawamura,(unknown),Jumpei Takeshita,Takeshi Matsumoto,Kazuya Monden,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Ryo Tachikawa,Kojiro Otsuka,Keisuke Tomii,Nobuyuki Katakami	41
12	Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor 2013 ·Cancer ·Akito Hata,Nobuyuki Katakami,Hiroshige Yoshioka,Jumpei Takeshita,Kosuke Tanaka,Shigeki Nanjo,Shiro Fujita,Reiko Kaji,Yukihiro Imai,Kazuya Monden,Takeshi Matsumoto,Kazuma Nagata,Kyoko Otsuka,Ryo Tachikawa,Keisuke Tomii,Kei Kunimasa,Masahiro Iwasaku,Akihiro Nishiyama,Tadashi Ishida,Yoshihiro Nishimura	153
13	Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma 2013 ·Lung Cancer ·Daichi Fujimoto,Keisuke Tomii,Takehiro Otoshi,Takahisa Kawamura,(unknown),(unknown),Kosuke Tanaka,Takeshi Matsumoto,Kazuya Monden,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Akito Hata,Ryo Tachikawa,Kojiro Otsuka,Hiroshi Hamakawa,Nobuyuki Katakami,Yutaka Takahashi,Yukihiro Imai	29
14	Detection of Herpes Viruses by Multiplex and Real-Time Polymerase Chain Reaction in Bronchoalveolar Lavage Fluid of Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome 2013 ·Respiration ·Ryo Tachikawa,Keisuke Tomii,Ryutaro Seo,Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Kojiro Otsuka,Hisako Hashimoto,Ken Watanabe,Norio Shimizu	25
15	Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a patient with poor performance status 2013 ·Respiratory Investigation ·(unknown),Kazuma Nagata,Kyoko Otsuka,Atsushi Nakagawa,Ryo Tachikawa,Kojiro Otsuka,Nobuyuki Katakami,Keisuke Tomii	14
16	Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease 2012 ·Respirology ·Kazuma Nagata,Keisuke Tomii,Kojiro Otsuka,Ryo Tachikawa,Kyoko Otsuka,(unknown),Kosuke Tanaka,Takeshi Matsumoto,Kazuya Monden	36
17	Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection 2011 ·Lung Cancer ·Akito Hata,Nobuyuki Katakami,Hiroshige Yoshioka,Shiro Fujita,Kei Kunimasa,Shigeki Nanjo,Kyoko Otsuka,Reiko Kaji,Keisuke Tomii,Masahiro Iwasaku,Akihiro Nishiyama,Hidetoshi Hayashi,Satoshi Morita,Tadashi Ishida	53
18	Malignant Melanoma of the Lung: Report of Two Cases 2011 ·Annals of Thoracic and Cardiovascular Surgery ·Shinya Neri,Teruya Komatsu,Jiro Kitamura,Kyoko Otsuka,Nobuyuki Katakami,Yutaka Takahashi	12
19	Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic 2011 ·Respiration ·Ryo Tachikawa,Keisuke Tomii,Hiroyuki Ueda,Kazuma Nagata,Shigeki Nanjo,(unknown),Kyoko Otsuka,(unknown),Michio Hayashi,Nobuyuki Katakami,Yukihiro Imai	101
20	Amrubicin at a lower-dose with routine prophylactic use of granulocyte-colony stimulating factor for relapsed small-cell lung cancer 2010 ·Lung Cancer ·Akito Hata,Nobuyuki Katakami,Shiro Fujita,Reiko Kaji,Shigeki Nanjo,Kyoko Otsuka,(unknown),(unknown),Ryo Tachikawa,Michio Hayashi,Takashi Nishimura,Keisuke Tomii	5

About Kyoko Otsuka

Kyoko Otsuka is a scholar working on Pulmonary and Respiratory Medicine, General Decision Sciences and Oncology, having authored 27 papers that have together received 749 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (613 citations), Oncology (358 citations) and Cancer Research (101 citations). Kyoko Otsuka has collaborated with scholars based in Japan, Australia and United States. Frequent co-authors include Keisuke Tomii, Kazuma Nagata, Nobuyuki Katakami, Ryo Tachikawa, Akito Hata, Shiro Fujita, Reiko Kaji, Kojiro Otsuka, Shigeki Nanjo and Takeshi Matsumoto. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact